Sign In
Buy VKTX
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026
2 Growth Stocks to Invest $1,000 in Right Now
12:15pm, Thursday, 18'th Dec 2025
A $1,000 investment can be an ideal amount to invest in an up-and-coming growth stock. The stocks below are still modest in size, with market capitalization of less than $6 billion.
1 Bold Prediction for Viking Therapeutics in 2026
01:15pm, Tuesday, 16'th Dec 2025
Takeover activity has been high lately in the intensely competitive anti-obesity drug space. Viking's pipeline may contain plenty of hidden value that a larger company might release.
2 Monster Stocks in the Making to Buy and Hold
10:30am, Tuesday, 16'th Dec 2025
The next 12 months will tell us more about their prospects.
Viking Therapeutics, Inc. (VKTX) Registers a Bigger Fall Than the Market: Important Facts to Note
06:45pm, Monday, 15'th Dec 2025
Viking Therapeutics, Inc. (VKTX) closed at $36.15 in the latest trading session, marking a -2.51% move from the prior day.
Investment strategist names 10 sub-$10 billion stocks to watch in 2026
03:32pm, Saturday, 13'th Dec 2025
Investment strategist Shay Boloor has outlined ten sub-$10 billion market-cap companies he believes are positioned to benefit from powerful long-term trends heading into 2026.
My Top 10 Stocks to Buy for 2026
04:10am, Saturday, 13'th Dec 2025
Together, these stocks offer you a balanced mix of growth and safety. These companies span a number of industries, and many are leaders in their markets.
Frontier Capital Management Co. LLC Increases Stock Holdings in Viking Therapeutics, Inc. $VKTX
04:12am, Friday, 12'th Dec 2025
Frontier Capital Management Co. LLC raised its stake in shares of Viking Therapeutics, Inc. (NASDAQ: VKTX) by 52.8% during the second quarter, according to the company in its most recent 13F filing wi
3 Underrated Growth Stocks That Look Like Great Buys Heading Into 2026
07:15am, Thursday, 11'th Dec 2025
The best-performing stock on this list is up just 4% this year. Investors may be undervaluing these companies' growth opportunities.
Viking Therapeutics: Prepping For A Critical 2026
08:57am, Saturday, 06'th Dec 2025
Viking Therapeutics is positioned for a pivotal 2026, advancing both injectable and oral VK2735 in obesity, with pipeline depth from an emerging amylin agonist program. VKTX's oral VK2735 has demonstr
VKTX Stock Rises 34% in Three Months: Here's What You Should Know
10:31am, Monday, 01'st Dec 2025
Viking Therapeutics' shares jump 34% as rapid VK2735 trial enrollment boosts optimism amid intensifying interest in obesity treatments.
Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It?
10:30am, Friday, 28'th Nov 2025
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Prediction: This Undervalued Stock Could Compete With Novo Nordisk by 2029
08:15am, Thursday, 27'th Nov 2025
Viking Therapeutics could enter the weight loss market by 2029. The company's leading candidate looks very promising.
Viking Therapeutics to Participate at the Piper Sandler 37th Annual Healthcare Conference
04:05pm, Tuesday, 25'th Nov 2025
SAN DIEGO , Nov. 25, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic an
2 Healthcare Stocks for Beginner Investors With a 20-Year Time Horizon
09:20am, Saturday, 22'nd Nov 2025
If you want to invest in top healthcare stocks, both of these are worth consideration. Pfizer is moving past the pandemic era, and tremendous growth could be ahead.
3 Weight-Loss Drug Stocks To Consider For 2026
01:58pm, Friday, 21'st Nov 2025
The global weight loss drug market, perhaps ironically, is growing like gangbusters these days. Globally, it's set to expand from $15 billion in 2024 to $150 billion by 2035, according to Morgan Stanl
